100 Investigational single agent orteronel (ortl, TAK-700) in patients with nonmetastatic castration-resistant prostate cancer (nmCRPC): Updated results
Hussain, M., Corn, P.G., Michaelson, D., Hammers, H.J., Alumkal, J.J., Ryan, C.J., Bruce, J.Y., Moran, S., Maclean, D., Lee, S-Y., Mortimer, P., George, D.J.Volume:
12
Language:
english
Journal:
European Urology Supplements
DOI:
10.1016/S1569-9056(13)60592-8
Date:
March, 2013
File:
PDF, 125 KB
english, 2013